Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

takeda_usa_pharmaceuticals_u

Takeda unveils three new discovery and development collaborations in immuno-oncology

January 4, 2019 Medical Communications, Research and Development CAR-T, Crescendo Biologics, Memorial Sloan Kettering Cancer Center, Noile-Immune, Takeda, pharma

Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese …
News
38707779504_4778627b30_z

Top Ten most popular articles on Pharmafile.com of 2018!

December 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10

Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10

Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …
News
liz_barrett

Novartis Oncology CEO steps down after 11 months

December 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Liz Barret, the CEO of Swiss firm Novartis Oncology has said that she is standing down after being in the …
Appointment
800px-t_lymphocyte_16760076824

KCL researchers find link between overactive immune system and Chronic Fatigue Syndrome/ ME

December 20, 2018 Research and Development CFS, KCL, King's College London, Kings College London, ME

Chronic fatigue syndrome (CFS) or Myalgic encephalomyelitis (ME) may be caused by an overactive immune system, according to researchers at …
News
8643990124_7c11fee008_z

Gilead and Scholar Rock collaborate on fibrosis in deal worth more than $80m

December 20, 2018 Business Services, Research and Development Califonia, Gilead, Scholar Rock, USA, fibrosis

California-based antiviral drugs specialist Gilead Sciences has entered into a strategic partnership with Cambridge, Massachusetts-based biotech Scholar Rock as part …
News
astrazeneca_plaque

AstraZeneca scores hat trick in ovarian cancer and anaemia clinical trials

December 20, 2018 Research and Development AstraZeneca, anaemia, oncology, ovarian cancer, pharma

Anglo-Swedish multinational AstraZeneca has revealed that its ovarian cancer drug (Lynparza) and anaemia treatment (Roxadustat) have met their goals in …
News

NICE recommends Lenvima as alternative first-line therapy for advanced liver cancer

December 19, 2018 Research and Development, Sales and Marketing Lenvima, NICE, UK, liver cancer, pharma

UK drug watchdog NICE has revealed that it has recommended Eisai’s Lenvima (lenvatinib) for use on the NHS in England …
News
astrazeneca-sign

China becomes first country to approve roxadustat in chronic kidney disease

December 19, 2018 Research and Development, Sales and Marketing AstraZeneca, China, chronic kidney disease, pharma

AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase inhibitor …
News
jj_sign_on_wall

Indian authorities seize J&J Baby Powder in response to Reuters report

December 19, 2018 Research and Development Cancer, India, J&J, JJ, asbestos, baby powder, regulation

Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after …
News
gsk_china_8

GSK and Pfizer combine healthcare units in multibillion dollar deal

December 19, 2018 Research and Development GSK, OTC, Pfizer, healthcare, merger

American multinational Pfizer and British firm GlaxoSmithKline are set to combine their consumer healthcare units in a venture worth billions. …
News

Novartis inks deal with Canadian cannabis firm Tilray

December 18, 2018 Research and Development Marijuana, Novartis, Sandoz, Tilray, cannabis

Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry …
News
82958bfc7df1311fd17a008495fc-1456375

Pharma in 2018: Looking back, looking forward

December 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, Alligator Bioscience, Eisai, Gilead, Mundipharma, pharma

2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …
Feature
pharmafile_autumn_2018

The Autumn 2018 edition of Pharmafile is available to read online now!

December 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunology, infectious diseases, pharma, pharmafile, rare diseases

The Autumn 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026